{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:12:55Z","timestamp":1791357175763,"version":"4.3.1"},"reference-count":19,"publisher":"American Psychiatric Association Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[1998,4,1]]},"DOI":"10.1176\/ajp.155.4.505","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T19:54:49Z","timestamp":1418846089000},"page":"505-508","source":"Crossref","is-referenced-by-count":99,"title":["Binding of Antipsychotic Drugs to Cortical 5-HT<sub>2A<\/sub> Receptors: A PET Study of Chlorpromazine, Clozapine, and Amisulpride in Schizophrenic Patients"],"prefix":"10.1176","volume":"155","author":[{"given":"Christian","family":"Trichard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Paill\u00e9re-Martinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Attar-Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Recassens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Monnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Martinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1554111","unstructured":"Meltzer HY, Matsubara S, Lee JC: Classification of typical and atypical antipsychotic drugs on the basis of dopamine D1, D2 and serotonin2 pKi values. J Pharmacol Exp Ther 1989; 251:238\u2013251"},{"key":"R1554112","doi-asserted-by":"crossref","unstructured":"Nordstr\u00f6m A-L, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G: D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am J Psychiatry 1995; 152:1444\u20131449","DOI":"10.1176\/ajp.152.10.1444"},{"key":"R1554113","doi-asserted-by":"crossref","unstructured":"Farde L, Nordstr\u00f6m AL, Wiesel FA, Pauli S, Halldin C, Sedvall G: Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classi~cal neuroleptics and clozapine: relation to extrapyramidal side effects. Arch Gen Psychiatry 1992; 49:538\u2013544","DOI":"10.1001\/archpsyc.1992.01820070032005"},{"key":"R1554114","doi-asserted-by":"crossref","unstructured":"Blin J, Sette G, Fiorelli M, Bletry O, Elghozi JL, Crouzel C, Baron JC: A method for in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone. J Neurochem 1990; 54:1744\u20131754","DOI":"10.1111\/j.1471-4159.1990.tb01229.x"},{"key":"R1554115","doi-asserted-by":"crossref","unstructured":"Leysen JE, Gommeren W: Drug-receptor dissociation time, new tool for drug research: receptor binding affinity and drug-receptor dissociation profiles of serotonin-S2, dopamine-D2, histamine-H1 antagonists, and opiates. Drug Dev Res 1986; 8:119\u2013131","DOI":"10.1002\/ddr.430080115"},{"key":"R1554116","doi-asserted-by":"crossref","unstructured":"Chivers JK, Gommeren W, Leysen JE, Jenner P, Marsden D: Comparison of the in-vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptors. J Pharm Pharmacol 1988; 40:415\u2013421","DOI":"10.1111\/j.2042-7158.1988.tb06306.x"},{"key":"R1554117","doi-asserted-by":"crossref","unstructured":"Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC: Molecular cloning characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1991; 347:146\u2013151","DOI":"10.1038\/347146a0"},{"key":"R1554118","doi-asserted-by":"crossref","unstructured":"Blin J, Crouzel C: Blood-cerebrospinal fluid and blood-brain barriers imaged by 18F-labeled metabolites of 18F-setoperone studied in humans using positron emission tomography. J Neurochem 1992; 58:2303\u20132310","DOI":"10.1111\/j.1471-4159.1992.tb10978.x"},{"key":"R1554119","doi-asserted-by":"crossref","unstructured":"Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ: A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 1984; 15:217\u2013227","DOI":"10.1002\/ana.410150302"},{"key":"R15541110","doi-asserted-by":"crossref","unstructured":"Blin J, Baron JC, Dubois B, Crouzel C, Fiorelli M, Attar-Levy D, Pillon B, Fournier D, Vidailhet M, Agid Y: Loss of brain 5-HT2 receptors in Alzheimer's disease. Brain 1993; 116:497\u2013510","DOI":"10.1093\/brain\/116.3.497"},{"key":"R15541111","doi-asserted-by":"crossref","unstructured":"Marcusson JO, Morgan DG, Winblad B, Finch CE: Serotonin-2 binding sites in human frontal cortex and hippocampus: selective loss of S-2A sites with age. Brain Res 1984; 311:51\u201356","DOI":"10.1016\/0006-8993(84)91397-0"},{"key":"R15541112","doi-asserted-by":"crossref","unstructured":"Gross-Isseroff R, Salama D, Israeli M, Biegon A: Autoradio~graphic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortem. Brain Res 1990; 519:223\u2013227","DOI":"10.1016\/0006-8993(90)90081-L"},{"key":"R15541113","doi-asserted-by":"crossref","unstructured":"Andree TH, Mikuni M, Tong CY, Koenig JI, Meltzer HY: Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex. J Neurochem 1986; 46:191\u2013197","DOI":"10.1111\/j.1471-4159.1986.tb12944.x"},{"key":"R15541114","doi-asserted-by":"crossref","unstructured":"Matsubara S, Meltzer HY: Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex. Life Sci 1989; 45:1397\u20131406","DOI":"10.1016\/0024-3205(89)90027-1"},{"key":"R15541115","doi-asserted-by":"crossref","unstructured":"Kane J, Honigfeld G, Singer J, Meltzer HY: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789\u2013796","DOI":"10.1001\/archpsyc.1988.01800330013001"},{"key":"R15541116","doi-asserted-by":"crossref","unstructured":"Claghorn J, Honigfeld G, Abuzzahab FS, Wang R, Steinbook R, Tuason V, Klerman G: The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol 1987; 7:377\u2013384","DOI":"10.1097\/00004714-198712000-00002"},{"key":"R15541118","doi-asserted-by":"crossref","unstructured":"Boyer P, Lecrubier Y, Puech AJ, Dewailly J, Aubin F: Treatment of negative symptoms in schizophrenia with amisulpride. Br J Psychiatry 1995; 166:68\u201372","DOI":"10.1192\/bjp.166.1.68"},{"key":"R15541119","doi-asserted-by":"crossref","unstructured":"Paill\u00e9re-Martinot M-L, Lecrubier Y, Martinot J-L, Aubin F: Improvement of some schizophrenic deficit symptoms with low doses of amisulpride. Am J Psychiatry 1995; 152:130\u2013133","DOI":"10.1176\/ajp.152.1.130"},{"key":"R15541120","doi-asserted-by":"crossref","unstructured":"Martinot J-L, Paill\u00e9re-Martinot M-L, Poirier MF, Dao-Castellana MH, Loc'h C, Mazi\u00e9re B: In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia. Psychopharmacology (Berl) 1996; 124:154\u2013158","DOI":"10.1007\/BF02245616"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.155.4.505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T18:59:29Z","timestamp":1721847569000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.155.4.505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4,1]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,4,1]]}},"alternative-id":["10.1176\/ajp.155.4.505"],"URL":"https:\/\/doi.org\/10.1176\/ajp.155.4.505","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,4,1]]}}}